Antonio Rueda-Domínguez

9PUBLICATIONS
54CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Haematological tumoursPredictive and prognostic markersMedical bacteriology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Feb 17, 2026
SEOM-TTCC clinical guideline for nasopharyngeal carcinoma (update 2025).

Antonio Rueda Domínguez, Beatriz Cirauqui, Almudena García Castaño

|Oct 20, 2025
Efficacy and Safety of Glofitamab Plus Polatuzumab Vedotin in Relapsed/Refractory Large B-Cell Lymphoma Including High-Grade B-Cell Lymphoma: Results From a Phase Ib/II Trial.

Martin Hutchings, Anna Sureda, Francesc Bosch

|Jan 08, 2023
Prognostic Impact of Sarcopenia in Patients with Advanced Prostate Carcinoma: A Systematic Review.

Pedro de Pablos-Rodríguez, Tasmania Del Pino-Sedeño, Diego Infante-Ventura

|Oct 21, 2022
Monitoring of Circulating Tumor DNA Predicts Response to Treatment and Early Progression in Follicular Lymphoma: Results of a Prospective Pilot Study.

Ismael Fernández-Miranda, Lucía Pedrosa, Marta Llanos

Pageof 2